Modern Diagnostic & Research Centre SME IPO GMP History
Modern Diagnostic & Research Centre SME IPO has been listed on January 7, 2026 at a listing price of ₹90, against the issue price of ₹90 — a gain of ₹0 (+0%). The GMP peaked at ₹14 on 10 January 2026 and reached a low of ₹14 on 10 January 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Modern Diagnostic & Research Centre SME IPO raised ₹0.41 Cr. Cr. through its IPO at a price band of ₹₹85 to ₹90 per share, with a lot size of 1600 shares. The IPO was open for subscription from 31 Dec 2025 to 02 Jan 2026.
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 25 Aug, 12:56 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 10 Jan 2026 | ₹ 14 | — | 16% | — | ₹ 18000 |
| 09 Jan 2026 | ₹ 14 | — | 16% | — | ₹ 18000 |
| 06 Jan 2026 | ₹ 14 | — | 16% | — | — |
Modern Diagnostic & Research Centre SME IPO dates
Key dates from opening to listing. Today is 17 November.
- Open 31 Dec 2025
- Close 02 Jan 2026
- Allotment 05 Jan 2026
- Refund/credit 06 Jan 2026
- Listing 07 Jan 2026
Modern Diagnostic & Research Centre SME IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹90 |
|---|---|
| Listing gain / loss | +₹0 per share |
| Listing date | 07 Jan, 2026 |
| Actual listing price | ₹90 (+0%) |
Is Modern Diagnostic & Research Centre SME IPO GMP reliable?
Grey market premium for Modern Diagnostic & Research Centre SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Modern Diagnostic & Research Centre SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Modern Diagnostic & Research Centre SME IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Modern Diagnostic & Research Centre SME IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was Retail: ₹18000. Unlike Kostak, Subject to Sauda only applies if you receive allotment.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Modern Diagnostic & Research Centre SME IPO
Modern Diagnostic & Research Centre was established with the aim of providing reliable and advanced diagnostic services to patients and healthcare providers. Over the years, the company has built a strong presence in the medical diagnostics space by adopting modern technology and maintaining quality standards. Promoted by experienced healthcare professionals, the centre focuses on delivering accurate and timely reports, helping doctors in effective diagnosis and treatment planning.
The company offers a wide range of services including pathology testing, radiology services such as X-ray, ultrasound, and other specialised diagnostic solutions. Its business model is centred around operating diagnostic centres and laboratories, generating revenue through test-based services and partnerships with hospitals and clinics. With a focus on customer trust, affordability, and expansion into new locations, the company continues to strengthen its footprint in the healthcare diagnostics sector.
Frequently asked
What is the GMP of Modern Diagnostic & Research Centre SME IPO?
The current Grey Market Premium (GMP) of Modern Diagnostic & Research Centre SME IPO is ₹ 14.
What is the Kostak Price of Modern Diagnostic & Research Centre SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Modern Diagnostic & Research Centre SME IPO is not available.
What is the Subject to Sauda Price of Modern Diagnostic & Research Centre SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is Retail: ₹18000.
What was the actual listing price of Modern Diagnostic & Research Centre SME IPO?
Modern Diagnostic & Research Centre SME IPO listed on January 7, 2026 at ₹90, against the issue price of ₹90 — a gain of +0%.
How did the GMP of Modern Diagnostic & Research Centre SME IPO trend before listing?
The GMP of Modern Diagnostic & Research Centre SME IPO was stable in its final days before listing. The GMP peaked at ₹14 on 10 January 2026. View the day-wise table above for the complete GMP history.
Explore Modern Diagnostic & Research Centre SME IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.